Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Altimmune (ALT) Assets Average (2016 - 2025)

Historic Assets Average for Altimmune (ALT) over the last 17 years, with Q3 2025 value amounting to $204.4 million.

  • Altimmune's Assets Average rose 2726.78% to $204.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $204.4 million, marking a year-over-year increase of 2726.78%. This contributed to the annual value of $175.0 million for FY2024, which is 1619.42% down from last year.
  • Latest data reveals that Altimmune reported Assets Average of $204.4 million as of Q3 2025, which was up 2726.78% from $173.8 million recorded in Q2 2025.
  • In the past 5 years, Altimmune's Assets Average registered a high of $260.8 million during Q2 2021, and its lowest value of $143.6 million during Q4 2024.
  • Moreover, its 5-year median value for Assets Average was $199.5 million (2024), whereas its average is $200.0 million.
  • In the last 5 years, Altimmune's Assets Average skyrocketed by 37036.71% in 2021 and then crashed by 2567.16% in 2025.
  • Over the past 5 years, Altimmune's Assets Average (Quarter) stood at $227.9 million in 2021, then decreased by 5.17% to $216.1 million in 2022, then fell by 12.72% to $188.6 million in 2023, then fell by 23.87% to $143.6 million in 2024, then soared by 42.35% to $204.4 million in 2025.
  • Its last three reported values are $204.4 million in Q3 2025, $173.8 million for Q2 2025, and $148.3 million during Q1 2025.